Physician profile
Christopher S Parham
NPI 1700271723
$2,819.94
in general payments reported to CMS, 2019-2025
11 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $387 · 2022: $895 · 2023: $682 · 2024: $624 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,537.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $609.60 | 2021-2022 | |
| Abbvie INC. | $490.27 | 2023-2024 | |
| Tela Bio, INC. | $448.04 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $364.53 | 2021-2023 | |
| Mentor Worldwide LLC | $256.17 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Integra Lifesciences Corporation | $217.11 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Axogen | $153.86 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Sanara Medtech INC. | $101.90 | 2022 | |
| Rti Surgical, INC | $93.30 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $53.78 | 2024 | |
| Depuy Synthes Sales INC. | $31.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Parham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.